BACKGROUND: Budesonide/formoterol maintenance and reliever therapy maintains asthma control and reduces exacerbation frequency compared with higher fixed-dose combination regimens. Its effects on eosinophilic airway inflammation and structure are unknown. OBJECTIVE: We sought to compare the effects of budesonide/formoterol 200/6 microg twice daily plus as-needed with budesonide/formoterol 800/12 microg twice daily on airway eosinophils and remodeling. METHODS: This 52-week, parallel-group, r...Expand abstract
- Publisher copy:
- Copyright date:
Airway inflammation in patients with asthma with high-fixed or low-fixed plus as-needed budesonide/formoterol.
If you are the owner of this record, you can report an update to it here: Report update to this record